Table 5 Summary of antimicrobial susceptibility of M. abscessus complex (MABSC) based on morphotypes
Drugs | N (%) of isolates (a) | p-value | |||||
|---|---|---|---|---|---|---|---|
Smooth (N = 84) | Rough (N = 56) | ||||||
S | I | R | S | I | R | ||
Amikacin | 82 (97.6) | 2 (2.4) | 0 | 45 (80.4) | 6 (10.7) | 5 (8.9) | < 0.001 * |
Cefoxitin | 2 (2.4) | 66 (78.6) | 16 (19.0) | 1 (1.8) | 37 (66.1) | 18 (32.1) | 0.172 |
Ciprofloxacin | 3 (3.6) | 9 (10.7) | 72 (85.7) | 1 (1.8) | 3 (5.4) | 52 (92.9) | 0.504 |
Clarithromycin (D3) | 78 (92.9) | 1 (1.2) | 5 (6.0) | 41 (73.2) | 0 | 15 (26.8) | < 0.001 * |
Doxycycline | 0 | 8 (9.5) | 76 (90.5) | 1 (1.8) | 3 (5.4) | 52 (92.9) | 0.33 |
Imipenem | 1 (1.2) | 48 (57.1) | 35 (41.7) | 1 (1.8) | 12 (21.4) | 43 (76.8) | < 0.001 * |
Linezolid | 13 (15.5) | 23 (27.4) | 48 (57.1) | 23 (41.1) | 14 (25.0) | 19 (33.9) | 0.002 * |
Moxifloxacin | 2 (2.4) | 1 (1.2) | 81 (96.4) | 0 | 2 (3.6) | 54 (96.4) | 0.494 |
TMP/SMX | 1 (1.2) | 0 | 83 (98.8) | 0 | 0 | 56 (100.0) | 1 |
Tobramycin | 0 | 5 (6.0) | 79 (94.0) | 1 (1.8) | 3 (5.4) | 52 (92.9) | 0.561 |